Novomix 30 Flexpen 3ml 5’s
NovoMix 30 FlexPen (Insulin Aspart Biphasic 100IU/mL) is a premixed insulin formulation used for managing Type 1 and Type 2 Diabetes Mellitus. It combines 30% rapid-acting Insulin Aspart with 70% intermediate-acting protamine-crystallized Insulin Aspart, providing both immediate and prolonged blood sugar control.
Each pack contains 5 pre-filled FlexPens, with each pen holding 3ml of insulin (100IU/mL). The FlexPen device is user-friendly, offering accurate dosing and convenient on-the-go insulin administration. NovoMix 30 is designed to cover mealtime glucose spikes and maintain basal insulin levels throughout the day.
Patients typically administer NovoMix 30 subcutaneously before meals, with dosing frequency determined by individual blood glucose monitoring and physician recommendations. The pen allows for easy and precise dose adjustments to ensure effective glycemic control.
NovoMix 30 FlexPen provides:
Rapid onset of action (within 10-20 minutes)
Peak effect at 1-4 hours
Duration of action up to 24 hours
Common injection sites include the abdomen, thighs, or upper arms. Rotation of injection sites helps minimize the risk of lipodystrophy.
Possible side effects include hypoglycemia, local injection site reactions, and mild weight gain. Patients should monitor blood glucose regularly and carry a source of fast-acting sugar to treat potential hypoglycemia.
Unopened FlexPens should be stored in a refrigerator at 2°C to 8°C. Once in use, the pen can be kept at room temperature (below 30°C) for up to 28 days.
NovoMix 30 FlexPen (Insulin Aspart Biphasic 100IU/mL) is a premixed insulin used in the treatment of Type 1 and Type 2 Diabetes Mellitus. It contains a combination of 30% soluble Insulin Aspart (rapid-acting) and 70% protamine-crystallized Insulin Aspart (intermediate-acting), offering both immediate mealtime glucose control and long-lasting basal insulin coverage.
This dual-action insulin profile helps manage postprandial (after-meal) blood sugar spikes while ensuring stable glucose levels between meals and overnight. NovoMix 30 is ideal for patients who prefer fewer daily injections while maintaining flexible dosing around meals.
Each pack contains 5 FlexPens, each pre-filled with 3ml of insulin (100IU/mL). The FlexPen system is designed for ease of use, allowing patients to dial precise doses effortlessly, making it convenient for both new and experienced insulin users.
Administration involves subcutaneous injections, typically given before meals. Common injection sites include the abdomen, thighs, or upper arms, and patients are advised to rotate sites to reduce the risk of skin complications.
NovoMix 30 starts working within 10-20 minutes, reaches its peak action in 1-4 hours, and has a duration of up to 24 hours, providing all-day glycemic coverage with just two or three injections per day.
Patients using NovoMix 30 should regularly monitor their blood glucose levels and adjust insulin doses based on medical advice. Hypoglycemia is the most common side effect, so it’s essential to recognize early symptoms such as dizziness, sweating, or palpitations.
Store unused FlexPens in a refrigerator at 2°C to 8°C. Once in use, the pen can be kept at room temperature (below 30°C) for a maximum of 28 days. Do not freeze or expose to direct sunlight.
For more diabetic management solutions and insulin products, explore our Medicine Category. Discover a wide range of pharmaceutical supplies at our online pharmacy shop.
Related products
